Higashiazai, Japan

Hiroyuki Muro

This inventor holds 2 USPTO granted patents. Top assignee: Kyoto Pharmaceutical Industries, Ltd.. Active years: 1990-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 34(Granted Patents)


Location History:

  • Higashiazai, JP (1990)
  • Shiga, JP (1995)

Company Filing History:


Years Active: 1990-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroyuki Muro: Innovator in Cephalosporin Compounds

Introduction

Hiroyuki Muro is a distinguished inventor based in Higashiazai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 2 patents to his name, Muro's work has garnered attention for its potential impact on antibacterial treatments.

Latest Patents

Muro's latest patents focus on cephalosporin compounds and their pharmaceutical compositions. These compounds are represented by a specific general formula, wherein various groups and atoms are defined to exhibit antibacterial activities. Notably, these compounds demonstrate effectiveness against Pseudomonas aeruginosa, a bacterium that is resistant to many known cephalosporin compounds. Additionally, they are effective against ordinary Gram-positive and Gram-negative bacteria, showcasing their potential in medical applications.

Career Highlights

Hiroyuki Muro is affiliated with Kyoto Pharmaceutical Industries, Ltd., where he continues to innovate in the pharmaceutical sector. His research and development efforts have led to advancements in antibacterial therapies, contributing to the ongoing fight against resistant bacterial strains.

Collaborations

Muro has collaborated with notable colleagues, including Satoru Hatano and Nobuharu Kakeya. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of their research.

Conclusion

Hiroyuki Muro's contributions to the field of cephalosporin compounds highlight his role as a key innovator in pharmaceuticals. His work not only addresses critical health challenges but also paves the way for future advancements in antibacterial treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…